Design Strategy for the EPR Tumor-Targeting of 1,2-Bis(sulfonyl)-1-alkylhydrazines

Philip G Penketh1, Hugh S Williamson2, Raymond P Baumann1

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA.